Jörn M Schattenberg, MD, FAASLD

Hepatology — University Medical Center of the Johannes Gutenberg University Mainz, Germany

LeadR Profile

3 130 ScienceLeadR Reputation 3130
Network Map

Hepatology

Subspecialties: Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026

Source: PubMed

University Medical Center of the Johannes Gutenberg University Mainz

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 727

Citations

Citations: 26 366 1st author: 81 Last author: 177 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Fibrosis-4 index and cardiac remodelling in the general population: The STANISLAS and African-PREDICT cohorts.
fibrosis
Am J Prev Cardiol20260
Risk of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis: a large-scale study from the Middle East.
liver diseases, fibrosis, liver, obesity, risk factors
Int J Obes (Lond)20260
Hearing loss and executive functions - results from a population-based cohort study.
cohort studies, perception, ear, executive function, hearing, air, audiometry, hearing loss, audiometry, pure-tone, speech
PLoS One20260
Validated early detection metrics reduce the population requiring liver fibrosis screening.
epidemiology, fibrosis, liver, prevalence
Gastroenterology20264
Propelling MASLD trials into the era of non-invasive tests.
liver diseases
Lancet Gastroenterol Hepatol Top journal20261

Clinical Studies 35

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 13
Phase 2 12
Phase 3 9
Phase 1 1

By status:

Completed 16
Active not recruiting 6
Recruiting 6
Not yet recruiting 3
Terminated 3
Unknown 1

By type:

Interventional 28
Observational 7

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 4
multicentric5to9 0
multicentricup10 26

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 70 years with alcohol related liver disease
2024-511596-15-00 — liver diseases, safety, liver, aged
Phase 2Recruiting2024
Essentiale liquid once daily Phase III study
2025-521678-32-00 — liver diseases, non-alcoholic fatty liver disease, liver diseases, alcoholic, multiple chronic conditions, liver, alcoholics, capsules, hepatitis b, hepatitis
Phase 3Active not recruiting2026
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction Associated Steatotic Liver Disease (SYNERGY Outcomes)
2025-522674-36-00 — liver diseases, liver
Phase 3Recruiting2026
Time restricted Feeding in MASLD
NCT07530809 — liver diseases, clinical protocols, fasting, life style, eating, liver, diet, energy intake, therapeutics, diet, healthy, intermittent fasting
N/ARecruiting2025
Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real life Setting
NCT07549607 — liver cirrhosis, biliary
N/ANot yet recruiting2026

LeadR Networks

Main global connection map